These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21544271)

  • 41. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infants and proton pump inhibitors: tribulations, no trials.
    Orenstein SR; Hassall E
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):395-8. PubMed ID: 18030202
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.
    Lee ES; Kim N; Lee SH; Park YS; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Aliment Pharmacol Ther; 2009 Jul; 30(2):154-64. PubMed ID: 19392871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship among proton pump inhibitors, bone disease and fracture.
    Targownik LE; Leslie WD
    Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor.
    Hershcovici T; Jha LK; Cui H; Powers J; Fass R
    Aliment Pharmacol Ther; 2011 Apr; 33(7):837-44. PubMed ID: 21261670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
    Hershcovici T; Fass R
    Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.
    Moayyedi P; Cranney A
    Am J Gastroenterol; 2008 Oct; 103(10):2428-31. PubMed ID: 18855852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
    Greenspan NR
    Med Health R I; 2011 Apr; 94(4):92-4. PubMed ID: 21667598
    [No Abstract]   [Full Text] [Related]  

  • 50. [Refractory gastroesophageal reflux disease (GERD) and PPI safety].
    Huerta-Iga FM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():1-3. PubMed ID: 24041041
    [No Abstract]   [Full Text] [Related]  

  • 51. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
    Beaumont H; Boeckxstaens GE
    Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton pump inhibitor utilization patterns in infants.
    Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Non response to proton pump inhibitors in gastroesophageal reflux disease].
    Lochner S; Kirch W
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1956. PubMed ID: 19760560
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
    Lee JH; Kim MJ; Lee JS; Choe YH
    Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton pump inhibitors: Adverse effects.
    Sataloff RT
    Ear Nose Throat J; 2010 Dec; 89(12):574-6. PubMed ID: 21174271
    [No Abstract]   [Full Text] [Related]  

  • 56. Prescribing proton pump inhibitors: is it time to pause and rethink?
    Vakil N
    Drugs; 2012 Mar; 72(4):437-45. PubMed ID: 22356286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What are the precautions with proton pump inhibitor use for reflux disease?
    Mospan CM
    JAAPA; 2015 Dec; 28(12):23-6. PubMed ID: 26595692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evidence and uncertainties on the clinical use of proton pump inhibitors].
    de Prados CM
    Gastroenterol Hepatol; 2010 May; 33 Suppl 1():5-10. PubMed ID: 20728783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.